GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (STU:6Y4) » Definitions » Tax Rate %

Vicore Pharma Holding AB (STU:6Y4) Tax Rate % : 0.11% (As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Vicore Pharma Holding AB Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Vicore Pharma Holding AB's Tax Expense for the three months ended in Sep. 2024 was €-0.01 Mil. Vicore Pharma Holding AB's Pre-Tax Income for the three months ended in Sep. 2024 was €-5.29 Mil. Therefore, Vicore Pharma Holding AB's Tax Rate % for the quarter that ended in Sep. 2024 was 0.11%.

Vicore Pharma Holding AB Tax Rate % Historical Data

The historical data trend for Vicore Pharma Holding AB's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Tax Rate % Chart

Vicore Pharma Holding AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.31 0.09 0.13 0.12

Vicore Pharma Holding AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.09 -0.29 0.18 0.11

Vicore Pharma Holding AB Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Vicore Pharma Holding AB's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=-0.034/-27.832
=0.12 %

Vicore Pharma Holding AB's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=-0.006/-5.286
=0.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB Tax Rate % Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (STU:6Y4) » Definitions » Tax Rate %
Comparable Companies
OSTO:DMYD B OSTO:GENO OSTO:XSPRAY OSTO:EGTX OSTO:BINV OSTO:HNSA OSTO:SANION OSTO:IBT B OSTO:ABLI OSTO:MAGLE VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
VICO:Sweden
Address
Kornhamnstorg 53, Stockholm, SWE, 111 27
Website
https://www.vicorepharma.com
Vicore Pharma Holding AB is as a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2a development for IPF. The company also has an investigational medical device in clinical development namely, Almee which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines